2018
Hybrid arch surgery challenges other forms of arch treatment
Wallen TJ, Bavaria JE, Vallabhajosyula P. Hybrid arch surgery challenges other forms of arch treatment. The Journal Of Cardiovascular Surgery 2018, 59: 554-558. PMID: 29687970, DOI: 10.23736/s0021-9509.18.10516-7.Peer-Reviewed Original ResearchConceptsHybrid arch proceduresHigh-risk patientsArch proceduresArch replacementRisk patientsTotal arch replacement procedureAcceptable postoperative outcomesSignificant comorbid burdenSignificant operative riskAortic arch replacementProspective randomized trialsTotal arch replacementAortic arch pathologiesOptimal surgical managementHybrid procedureArch surgeryComorbid burdenPostoperative mortalityAortic remodelingArch pathologiesOperative riskPostoperative outcomesSignificant comorbiditiesCirculatory arrestCase series
2012
Hybrid approaches in the treatment of aortic arch aneurysms: Postoperative and midterm outcomes
Bavaria J, Vallabhajosyula P, Moeller P, Szeto W, Desai N, Pochettino A. Hybrid approaches in the treatment of aortic arch aneurysms: Postoperative and midterm outcomes. Journal Of Thoracic And Cardiovascular Surgery 2012, 145: s85-s90. PMID: 23260461, DOI: 10.1016/j.jtcvs.2012.11.044.Peer-Reviewed Original ResearchMeSH KeywordsAgedAorta, ThoracicAortic Aneurysm, ThoracicBlood Vessel ProsthesisBlood Vessel Prosthesis ImplantationCardiopulmonary BypassEndoleakEndovascular ProceduresFemaleHeart Arrest, InducedHospital MortalityHumansKaplan-Meier EstimateMaleMiddle AgedParaplegiaPhiladelphiaReoperationRisk FactorsStentsSternotomyStrokeTime FactorsTreatment OutcomeConceptsAortic arch aneurysmThoracic endovascular repairArch vessel debranchingArch aneurysmMidterm outcomesAverage cardiopulmonary bypass timeType 1Aortic arch surgeryAortic reoperation ratesCardiopulmonary bypass timeGreater comorbid burdenHybrid arch repairSafe treatment modalityAscending Aortic AneurysmCirculatory arrest timeMedian sternotomy approachGood midterm resultsPercent of casesType III repairType II repairArch surgeryComorbid burdenCrossclamp timeParaplegia ratePostoperative endoleaks
2011
Age Differences in Primary Prevention Implantable Cardioverter‐Defibrillator Use in U.S. Individuals
Tsai V, Goldstein MK, Hsia HH, Wang Y, Curtis J, Heidenreich PA, Registry O. Age Differences in Primary Prevention Implantable Cardioverter‐Defibrillator Use in U.S. Individuals. Journal Of The American Geriatrics Society 2011, 59: 1589-1595. PMID: 21883101, DOI: 10.1111/j.1532-5415.2011.03542.x.Peer-Reviewed Original ResearchConceptsICD RegistryICD useNonarrhythmic deathHigh riskImplantable cardioverter-defibrillator (ICD) useHigh comorbid burdenPrior myocardial infarctionRisk of deathHigh-risk individualsRisk stratification systemOlder U.S. adultsYounger age groupsComorbid burdenICD implantationEjection fractionICD recipientsPrimary preventionRetrospective studyMyocardial infarctionMortality riskLower riskAge groupsU.S. adultsYounger groupOlder adults
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply